5 smallcap stocks outperformed with gains of nearly 8% to 11% on Sensex slump

The Sensex ended 287.70 points or 0.48% lower at 59,543.96. The benchmark opened over 60,000 points, however, bounced back on the back of selling in FMCG, banking and consumer durables stocks. like heavyweight Reliance IndustriesNestle, HUL, Bajaj Twin, HDFC and Kotak Bank registered further declines.

BSE little hat The index also bore the brunt of broadly bearish markets. The index closed at 28,747.94, down 100.48 points, or 0.35%. 5 stocks on the index outperformed with a jump of 9% to 17%.

On the performance of the markets, Vinod Nair, Head of Research, Geojit Financial Services said, “Domestic Market With FMCG and private banks putting pressure on the benchmark, they cut their early gains. Market focus has shifted to central bank policy announcements since the European Central Bank expected a hike in interest rates at its upcoming policy meeting. Imminent US GDP data will give additional clarity to the expectation that the Fed will ease its aggression with regard to rate hikes.”

Here is a list of small-caps that outperformed the indices on Tuesday:

South Indian Bank:

This Kerala bank reached a new 52-week high with a gain of over 17% during the trading session 13.88 each on BSE. However, stock. ended on 13.14 each on the exchange, an increase of 10.79%. The market cap of the lender is approx. 2,749.86 crore.

Year-over-year, the stock on Dalal Street is up nearly 43%.

The reason for great buying in South Indian Bank was due to its strong performance in Q2FY23.

During the second quarter of the current financial year, the bank earned a net profit of 223.10 crore as compared to a loss of Rs. 187.06 crore in Q2FY22. PAT is also from above 115.35 crore in Q1FY23. Net Interest Income (NII) remained on Q2FY23 vs . 726.37 crore in 527.15 crore in Q2FY22 and 603.38 crore in Q1FY23.

In the quarter, the asset quality improved with the bank’s gross NPAs coming in at 5.67%, from 6.65% in Q2FY22 and 5.87% in Q1FY23.

South Indian Bank is a private sector bank in India that provides a wide range of banking services to the customers.

NACL Industries:

Shares of NACL climbed over 16% to touch day’s high on Tuesday on BSE 91.65 each. Share though. ended on 86.65 each on the exchange, an increase of 9.89%. Its market cap is approx. 1,719.05 crores.

NACL has pan India presence and is one of the top Indian agrochemical companies. The company has over 50 products across all major crops and most geographies. It has a strong logistic presence with over 56 stock points across India for faster deliveries.

In Q2FY23, the company filed PAT of above 30 crores 25 crore in the same quarter last year. EBITDA stood on 58 cr in Q2FY23. more than 47 crores was recorded in Q2FY22. Total income for the quarter came in 569 crore, growing 27% year-on-year.

Exports contributed 40% of the total revenue during the first half of FY 2023. The company is actively working on new product registrations and brand building in new geographies.

Pawan Kumar, MD & CEO, said, “With operationalization of our greenfield site at Dahej and brownfield capacity expansion plans underway at Srikakulam, we are poised to leverage favorable tailwinds for the upcoming rabi season, and for H2 The outlook looks positive.”

NACL has declared the first interim dividend of 0.30 per share (30% of the face value) for the financial year 2013 at a face value of Re 1 each fully paid up.

Multi Commodity Exchange of India (MCX):

MCX shares touched 1,500 epic mark on Tuesday. Shares closed near their intraday high 1,494.45 each gained 9.10% on the BSE. Overall, the stock gained 9.5 per cent. Its market cap is approx. 7,621.45 crores.

MCX has also announced its financial performance for Q2FY23 where it has registered a growth of 94% in Net Profit 63.27 crore from 32.66 crore in the second quarter of FY22. Net profit margin stood at 43%. 47% year-on-year increase in total income 145.64 crores. While EBITDA rose 68% year-on-year 83.84 crores. A total of 20,767.5 MT of Base Metal has been delivered through exchange mechanism during Q2 FY22-23 as against 17,691.5 MT in Q2 FY21-22. MCX had a market share of 96.8% in the commodity futures market for the first half of FY 22-23.

Analysts are upbeat about the growth in MCX shares. In a report, research analysts at ICICI Securities said, “Our estimate factor ADTV in FY23/24 futures is Rs 260/270 billion (H1FY22: Rs 242 billion) and options ADTV at Rs 295/390 billion (H1FY22: Rs 355 billion). Rs, Oct’22: Rs 368 billion) ) Accordingly, we anticipate total revenue of Rs 4.6 billion / Rs 5 in FY 23/24. We expect total operating expenses of Rs 2.5 billion in FY 2013 , which is an additional one-time expense of Rs 200 million on account of software expenses (our estimate). 63. Extension of contract with

Moon. Our total operating expenses for FY24 are estimated at Rs 2.2 billion (including the benefit of lower software costs). Accordingly, we anticipate EBITDA margins to be 46%/55% respectively in FY 2013/24.”

The analysts’ note said, “We expect core PAT of Rs 2.2 billion (CAGR of 23% between FY22-24 driven by lower software costs). On a 35x FY24E core EPS basis, Rs 1,700 (unchanged unchanged) Maintain Buy with an unchanged target price of Rs.43.4 and free cash of Rs.180 per share.

MCX is a state-of-the-art, commodity derivatives exchange that facilitates online trading of commodity derivatives transactions, thereby providing a platform for price discovery and risk management.

Ramki Infrastructure:

Ramky Infra contracts for execution of government projects across the country. Directly developed projects include several BOT/BOOT projects, industrial parks and more.

Ramky Infra shares hit new 52-week high on Tuesday 272 each. Overall, the stock gained around 11 per cent on the day. However, the stock returned during closing hours and ended at 267.25 each on the BSE, up 9.04%. Its market cap is approx. 1,849.31 crore.

So far, in 2022, the stock has risen over 29% on Dalal Street. But in one year, the stock’s gain on the exchange has grown to over 90%. stock was close 140 level on October 25 last year.

Neureca:

Neureka is a leading healthcare and wellness company with a product range of over 150 SKUs across various categories.

On BSE, small-cap stocks traded . advanced almost 10% by hitting intraday highs of 818 each. However, stock. ended on 803.90 each, an increase of 7.8%. Its market cap is approx. 803.91 crores.

This small-cap stock has lost a lot in one year. had stock 1,738 level on October 25 last year. while the stock was above 2,000 marks in the first week of January this year.

The stock has a 52-week high 2,175.20 each.

There is a possibility of buying in the stock.

Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.